These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
184 related items for PubMed ID: 3115194
21. [Various characteristics of the structure and synthesis of procollagens produced by cultured skin fibroblasts from patients with Danlos-Ehlers syndrome type I]. Sokolov BP, Sher BM, Lomova TIu, Kukharenko VI, Blinnikova OE. Mol Gen Mikrobiol Virusol; 1987 Jan; (1):19-23. PubMed ID: 3561422 [Abstract] [Full Text] [Related]
22. The kyphoscoliotic type of Ehlers-Danlos syndrome (type VI): differential effects on the hydroxylation of lysine in collagens I and II revealed by analysis of cross-linked telopeptides from urine. Eyre D, Shao P, Weis MA, Steinmann B. Mol Genet Metab; 2002 Jul; 76(3):211-6. PubMed ID: 12126935 [Abstract] [Full Text] [Related]
23. Ehlers-Danlos syndrome type VI: clinical manifestations of collagen lysyl hydroxylase deficiency. Wenstrup RJ, Murad S, Pinnell SR. J Pediatr; 1989 Sep; 115(3):405-9. PubMed ID: 2504907 [Abstract] [Full Text] [Related]
24. Understanding genetic disorders of collagen. Krane SM. N Engl J Med; 1980 Jul 10; 303(2):101-2. PubMed ID: 7383059 [No Abstract] [Full Text] [Related]
25. Ehlers-Danlos Syndrome Type VI (EDS VI): problems of diagnosis and management. Heim P, Raghunath M, Meiss L, Heise U, Myllylä R, Kohlschütter A, Steinmann B. Acta Paediatr; 1998 Jun 10; 87(6):708-10. PubMed ID: 9686670 [Abstract] [Full Text] [Related]
26. [Ehlers-Danlos syndrome. Description of 2 clinical cases]. Ottolini A, Berardinelli A, Besana D, Cetta G, Dyne KM, Lanzi G. Minerva Pediatr; 1992 May 10; 44(5):231-6. PubMed ID: 1620075 [Abstract] [Full Text] [Related]
27. Defects in the biochemistry of collagen in diseases of connective tissue. Uitto J, Lichtenstein JR. J Invest Dermatol; 1976 Feb 10; 66(02):59-79. PubMed ID: 1448 [Abstract] [Full Text] [Related]
28. The mRNA and the activity of lysyl hydroxylase are up-regulated by the administration of ascorbate and hydralazine to human skin fibroblasts from a patient with Ehlers-Danlos syndrome type VI. Yeowell HN, Walker LC, Marshall MK, Murad S, Pinnell SR. Arch Biochem Biophys; 1995 Aug 20; 321(2):510-6. PubMed ID: 7646078 [Abstract] [Full Text] [Related]
29. Another mechanism for the defect in type III collagen accumulation in Ehlers-Danlos syndrome type IV: increased intracellular degradation of the procollagen. Utani A, Tanaka T, Nishigori C, Miyachi Y, Danno K, Imamura S, Hosokawa M, Takeda T, Hirayoshi K, Nagata K. Lab Invest; 1990 Aug 20; 63(2):181-8. PubMed ID: 2199725 [Abstract] [Full Text] [Related]
30. Ehlers-Danlos syndrome and type III collagen abnormalities: a variable clinical spectrum. Hamel BC, Pals G, Engels CH, van den Akker E, Boers GH, van Dongen PW, Steijlen PM. Clin Genet; 1998 Jun 20; 53(6):440-6. PubMed ID: 9712532 [Abstract] [Full Text] [Related]
32. Pathomorphological and biochemical alterations in Ehlers-Danlos-syndrome type IV. Nerlich AG, Stöss H, Lehmann H, Krieg T, Müller PK. Pathol Res Pract; 1994 Aug 20; 190(7):697-706; discussion 706-7. PubMed ID: 7808968 [Abstract] [Full Text] [Related]
33. Defect in conversion of procollagen to collagen in a form of Ehlers-Danlos syndrome. Lichtenstein JR, Martin GR, Kohn LD, Byers PH, McKusick VA. Science; 1973 Oct 19; 182(4109):298-300. PubMed ID: 4742738 [Abstract] [Full Text] [Related]
34. Defective glycosylation of decorin and biglycan, altered collagen structure, and abnormal phenotype of the skin fibroblasts of an Ehlers-Danlos syndrome patient carrying the novel Arg270Cys substitution in galactosyltransferase I (beta4GalT-7). Seidler DG, Faiyaz-Ul-Haque M, Hansen U, Yip GW, Zaidi SH, Teebi AS, Kiesel L, Götte M. J Mol Med (Berl); 2006 Jul 19; 84(7):583-94. PubMed ID: 16583246 [Abstract] [Full Text] [Related]
35. Defects in the processing of procollagen to collagen are demonstrable in cultured fibroblasts from patients with the Ehlers-Danlos and osteogenesis imperfecta syndromes. Minor RR, Sippola-Thiele M, McKeon J, Berger J, Prockop DJ. J Biol Chem; 1986 Jul 25; 261(21):10006-14. PubMed ID: 3733683 [Abstract] [Full Text] [Related]
36. Abnormally soluble collagen produced in fibroblasts cultures. Francis G, Donnelly PV, Di Ferrante N. Experientia; 1976 Jun 15; 32(6):691-3. PubMed ID: 950007 [Abstract] [Full Text] [Related]
37. Tenascin-X deficiency mimics Ehlers-Danlos syndrome in mice through alteration of collagen deposition. Mao JR, Taylor G, Dean WB, Wagner DR, Afzal V, Lotz JC, Rubin EM, Bristow J. Nat Genet; 2002 Apr 15; 30(4):421-5. PubMed ID: 11925569 [Abstract] [Full Text] [Related]
38. P3h3-null and Sc65-null Mice Phenocopy the Collagen Lysine Under-hydroxylation and Cross-linking Abnormality of Ehlers-Danlos Syndrome Type VIA. Hudson DM, Weis M, Rai J, Joeng KS, Dimori M, Lee BH, Morello R, Eyre DR. J Biol Chem; 2017 Mar 03; 292(9):3877-3887. PubMed ID: 28115524 [Abstract] [Full Text] [Related]
39. Genotyping and prenatal assessment of collagen lysyl hydroxylase deficiency in a family with Ehlers-Danlos syndrome type VI. Dembure PP, Priest JH, Snoddy SC, Elsas LJ. Am J Hum Genet; 1984 Jul 03; 36(4):783-90. PubMed ID: 6089551 [Abstract] [Full Text] [Related]
40. Transcriptional activation of type I collagen genes by ascorbic acid 2-phosphate in human skin fibroblasts and its failure in cells from a patient with alpha 2(I)-chain-defective Ehlers-Danlos syndrome. Kurata S, Senoo H, Hata R. Exp Cell Res; 1993 May 03; 206(1):63-71. PubMed ID: 8482361 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]